Cypherpunk Invests $50M in Zcash, Rebrand Spurs 300% Rally
Cypherpunk Technologies, formerly Leap Therapeutics, has rebranded and shifted from biotech to a crypto treasury model. The Nasdaq-listed firm raised $58.9M in a private placement led by Winklevoss Capital and allocated $50M to purchase 203,775 Zcash tokens at an average price of $245.37. Since the acquisition, Zcash has more than doubled, trading near $531 and up over 12% in the past 24 hours, driving a 300% surge in Cypherpunk’s shares. The company added Khing Oei as chairman and appointed Will McEvoy as chief investment officer to strengthen its digital asset strategy. Traders should monitor Zcash market indicators, liquidity trends and RSI levels as institutional demand and privacy features influence price momentum and long-term demand.
Bullish
Cypherpunk’s $50M Zcash purchase and 300% stock rally reflect robust institutional demand for privacy tokens. In the short term, the heavy buy has bolstered Zcash’s price momentum and lifted trading volumes, suggesting bullish sentiment among crypto traders. However, Zcash’s RSI at record highs signals a potential correction, prompting traders to watch for pullbacks. In the long term, Cypherpunk’s crypto treasury strategy, backed by Winklevoss Capital and bolstered by new leadership appointments, could support sustained demand and price stability for Zcash. Overall, the move underscores growing institutional confidence in privacy-focused digital assets, reinforcing a bullish outlook for ZEC.